Unique stem cell lines identifier | NIAi002-A NIAi002-A-1 NIAi002-A-2 NIAi002-A-3 NIAi003-A NIAi003-A-1 NIAi003-A-2 NIAi003-A-3 |
| |
Alternative names of stem cell lines | A53T SNCA 40760 (NIAi002-A) Iso-WT SNCA 40760 PL1E11 (NIAi002-A-1) Iso-WT SNCA 40760 PL3B3 (NIAi002-A-2) Iso-WT SNCA 40760 PL3B7 (NIAi002-A-3) A53T SNCA 42720 (NIAi003-A) Iso-WT SNCA 42720 PL2B9 (NIAi003-A-1) Iso-WT SNCA 42072 PL2C11 (NIAi003-A-2) Iso-WT SNCA 42072 PL3G1 (NIAi003-A-3) |
| |
Institution | National Institutes of Health, National Institute on Aging |
| |
Contact information of distributor | Mark R Cookson: cookson@mail.nih.gov |
| |
Type of cell lines | iPSC |
| |
Origin | Human |
Cell Source | The Michael J. Fox Foundation for Parkinson’s Research (MJFF), Parkinson’s Progression Markers Initiative (PPMI). |
| |
Clonality | Clonal |
| |
Method of reprogramming | Sendai virus |
| |
Multiline rationale | Isogenic clones from two unrelated donors carrying the same pathogenic variant in a PD related gene |
| |
Gene modification | Yes |
| |
Type of modification | Revert SNCA p.A53T to WT sequence |
| |
Associated disease | Parkinson’s disease |
| |
Gene/locus | SNCA/PARK1 |
| |
Method of modification | RNP CRISPR/Cas9 |
| |
Name of transgene or resistance | N/A |
| |
Inducible/constitutive system | N/A |
| |
Date archived/stock date | N/A |
| |
Cell line repository/bank | Indiana University https://hpscreg.eu/cell-line/NIAi002-A https://hpscreg.eu/cell-line/NIAi002-A-1 https://hpscreg.eu/cell-line/NIAi002-A-2 https://hpscreg.eu/cell-line/NIAi002-A-3 https://hpscreg.eu/cell-line/NIAi003-A https://hpscreg.eu/cell-line/NIAi003-A-1 https://hpscreg.eu/cell-line/NIAi003-A-2 https://hpscreg.eu/cell-line/NIAi003-A-3 |
| |
Ethical approval | Original line obtained from MJFF. Ethical licence/Sponsor Protocol number: 001. |